A Win For GlycoMimetics, Inc.
Tue, Oct 29, 2024 at 07:29 PM
GlycoMimetics, Inc. (GLYC:NASDAQ) shot up at $0.49, representing a gain of 191.3%. On Tue, Oct 29, 2024, GLYC:NASDAQ touched a New 2-Week High of $0.49. The stock appeared on our News Catalysts scanner on Tue, Oct 29, 2024 at 10:21 AM in the 'AGREEMENT' category. From Tue, Oct 15, 2024, the stock recorded 40.00% Up Days and 45.45% Green Days
The stock spiked on Tue, Oct 29, 2024 at $0.63 with a volume of 1B+.
About GlycoMimetics, Inc. (GLYC:NASDAQ)
GlycoMimetics Inc is a clinical stage biotechnology company. It is engaged in discovery and development of novel glycomimetic drugs to address unmet medical needs resulting from diseases in which carbohydrate biology plays a key role.
Top 10 Gainers:
- GlycoMimetics, Inc. (GLYC:NASDAQ), 191.32%
- Smart for Life Inc. (SMFL:NASDAQ), 172.09%
- BIO-key International, Inc. (BKYI:NASDAQ), 81.09%
- J-Long Group Limited (JL:NASDAQ), 69.85%
- GeneDx Holdings Corp Cl A (WGS:NASDAQ), 49.88%
- Profire Energy, Inc. (PFIE:NASDAQ), 46.2%
- Histogen Inc. (HSTO:NASDAQ), 41.18%
- Shuttle Pharmaceuticals Holdings Inc. (SHPH:NASDAQ), 36.36%
- Lightbridge Corporation (LTBR:NASDAQ), 35.57%
- Kuke Music Holding Limited American Depositary Shares each representing one (KUKE:NYSE), 31.85%